Endocrine toxicity of immune checkpoint inhibitors: a network meta-analysis of the current evidence
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being. Existing research has often been limited in scope and has not provided comprehensi...
Saved in:
Main Authors: | Peipei Ouyang (Author), Weiting Yang (Author), Jianqiao Sun (Author), Ping Chen (Author), Qingyun He (Author), Jiaxin Yan (Author), Wenhao Wang (Author), Yi Wang (Author), Heran Li (Author), Qiuhua Luo (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021) -
Cardiovascular toxicity profile of immune response checkpoint inhibitors
by: Andrei V. Vazhenin, et al.
Published: (2024) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
by: Di Wang, et al.
Published: (2021) -
Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
by: Víctor Albarrán, et al.
Published: (2022) -
Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
by: Haiyang Wang, et al.
Published: (2019)